Significance of the F-18 FET PET in treatment planning for brain tumors.

被引：0
|
作者：
Polat, B. [1 ]
Verburg, F. A. [2 ]
Ludwig, V. [1 ]
Guckenberger, M. [1 ]
Richter, A. [1 ]
Kreissl, M. [2 ]
Lorenz, R. [2 ]
Reiners, C. [2 ]
Flentje, M. [1 ]
Sweeney, R. [1 ]
机构：
[1] Univ Wurzburg, Klin Strahlentherapie, Wurzburg, Germany
[2] Univ Wurzburg, Klin Nuklearmedizin, Wurzburg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2010年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] Assessment of hypoxia using F-18 fluoromisonidazole PET in brain gliomas and correlation of F-18 FDG PET and GdDTPA enhanced MRI
    Yamamoto, Yuka
    Kawai, Nobuvuki
    Kudomi, Nobuvuki
    Nishiyama, Yoshihiro
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [42] NORMAL BRAIN F-18 FDG PET AND MRI ANATOMY
    SCHIFTER, T
    TURKINGTON, TG
    BERLANGIERI, SU
    HOFFMAN, JM
    MACFALL, JR
    PELIZZARI, CA
    TIEN, RD
    COLEMAN, RE
    CLINICAL NUCLEAR MEDICINE, 1993, 18 (07) : 578 - 582
  • [43] [18F]FLT PET for diagnosis and staging of thoracic tumors.
    Dittmann, H
    Dohmen, BM
    Paulsen, F
    Wehrmann, M
    Bares, R
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 134P - 134P
  • [44] 18F-DOPA PET superior for staging of neuroendocrine tumors.
    Koopmans, KP
    de Vries, EGE
    Kema, IP
    van der Horst-Schrivers, ANA
    Elzinga, PH
    Jager, PL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 329S - 329S
  • [45] Use of 18F-FLT-PET to assess the metabolic activity of primary and metastatic brain tumors.
    Bendaly, EA
    Sloan, AE
    Dohmen, BM
    Mangner, TJ
    Machulla, HJ
    Bares, R
    Muzik, O
    Shields, AF
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 111P - 112P
  • [46] Role of 18F-DOPA PET/CT in Pediatric Brain Tumors. A Pilot Study.
    Piccardo, A.
    Morana, G.
    Rossi, A.
    Altrinetti, V.
    Nozza, P.
    Lopci, E.
    Cistaro, A.
    Cama, A.
    Cabria, M.
    Garre, M.
    Villavecchia, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S209 - S209
  • [47] F-18 FDG PET and C-11 MET PET findings in patients with five miscellaneous brain tumors
    Nishii, R
    Kawano, H
    Tani, A
    Nakamura, K
    Wakamatsu, H
    Umemura, Y
    Ogita, A
    Fujimoto, T
    Nagamachi, S
    Fujita, S
    Futami, S
    Kuratsu, J
    Nakajo, M
    Tamura, S
    Kawai, K
    PET AND MOLECULAR IMAGING: STATE OF THE ART AND FUTURE PERSPECTIVES, 2004, 1264 : 212 - 216
  • [48] Evaluation of gynecological tumors and endometriosis using [F-18]-fluoroestradiol and PET
    Okazawa, H.
    Yoshida, Y.
    Mori, T.
    Tsuchida, T.
    Kurokawa, T.
    Kobayashi, M.
    Tsujikawa, T.
    Yonekura, Y.
    Fujibayashi, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S264 - S264
  • [49] Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies
    Sun, HH
    Collins, JM
    Mangner, TJ
    Muzik, O
    Shields, AF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (03) : 343 - 348
  • [50] Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies
    Haihao Sun
    Jerry M. Collins
    Thomas J. Mangner
    Otto Muzik
    Anthony F. Shields
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 343 - 348
12345